CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2009; 30(S 01): 38-45
DOI: 10.1055/s-0041-1733342
Original Article

Metastatic Tumours in Ovaries

Prasenjit Das
Department of Pathology, All India institute of Medical Sciences, New Delhi, India
,
Narender Kumar
Department of Pathology, All India institute of Medical Sciences, New Delhi, India
,
Siddhartha DATTA Gupta
Department of Pathology, All India institute of Medical Sciences, New Delhi, India
› Author Affiliations


Publication History

Article published online:
02 March 2022

© 2009. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Arguello F, Baggs RB, Eskenazi AE, Duerst RE, Frantz CN. Vascular anatomy and organ-specific tumour growth as critical factors in the development of metastases and their distribution among organs. Int J Cancer 1991; 48: 583-90.
  • 2 Moore RG, Chung M, Granai GO, Gajewski W, Steinhoff MM: Incidence of metastasis to the ovaries from nongenital tract tumours. Gynecol Oncol, 2004; 93: 87-91.
  • 3 Yada-Hashimoto N, Yamamoto T, Kamiura S, Seino H, Ohira H, Sawai K, Kimura T, Saji F: Metastatic ovarian tumours: a review of 68 cases. Gynecol Oncol, 2003; 89: 314-317.
  • 4 Ulbright TM, Roth LM, Stehman FB: Secondary ovarian neoplasia: a clinicopathologic study of 35 cases. Cancer, 1984; 53: 1164-1174.
  • 5 Young RH, Path FRC, Scully RE: Metastatic tumours of the ovary. In: Blaustein’s pathology of the female genital tract,Kurman RJ (Ed), pp 1063-1101, Springer-Verlag, New York, 2002.
  • 6 Prat J, editor. Pathology of the ovary. Philadelphia: Saunders; 2004.
  • 7 Singh N, Lowe D. Metastases in the ovary. In: Jakobs IJ, Shepherd JH, Oram DH, Blackett AD, Lu-esley DM, Berchuck A, et al. editors. Ovarian cancer. 2nd edition. Oxford: University Press; 2002. p. 85-9.
  • 8 Young RH, Hart WR. Metastases from carcinoma of the pancreas simulating primary mucinous tumours of the ovary. A report of seven cases. Am J Surg Pathol 1989;13(7):748-56.
  • 9 Petru E, Pickel H, Heydarfadai M, Lahousen M, Haas J, Schaider H, et al. Nongenital cancers metastatic to ovary. Gynecol Oncol 1992;44(1): 83-6.
  • 10 Hann L, Lui D, Shi W, Bach A, Selland DL, Castieli M. Adnexal masses in women with breast cancer:cUS findings with clinical and histopathologic correlation. Radiology 2000;216:242-7.
  • 11 Tornos C, Soslow R, Chen S, Akram M, Hummer AJ, Abu-Rustum N, et al. Expression of WT1, CA 125 and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary. Am J Surg Pathol 2005;29(11):1482-9.
  • 12 Greene HJ, Grusetz MW, Mackles A: Subsequent second primary and metastatic cancer of the ovary. Clin Obstet Gynecol 1969;12: 972–979.
  • 13 Webb MJ, Decker DG, Mussey E: Cancer metastatic to the ovary:Factors influencing survival. Obstet Gynecol 1975;45:391–396.
  • 14 Mazur MT, Hsueh S, Gersell DJ: Metastases to the female genital tract. Analysis of 325 cases. Cancer 1984;53:1978–1984.
  • 15 Demopoulos RI, Touger L, Dubin N: Secondary ovarian carcinoma: A clinical and pathological evaluation. Int J GynecolPathol 1987;6:166–175.
  • 16 Gagnon Y, Tetu B: Ovarian metastases of breast carcinoma.A clinicopathologic study of 59 cases. Cancer 1989;64:892–898.
  • 17 Petru E, Pickel H, Heydarfadai M, et al.: Nongenital cancersmetastatic to the ovary. Gynecol Oncol 1992;44:83–86.
  • 18 Fujiwara K, Ohishi Y, Koike H, Sawada S, Moriya T, Kohno I:Clinical implications of metastases to the ovary. Gynecol Oncol 1995;59:124–128.
  • 19 Yada-Hashimoto N, Yamamoto T, Kamiura S, et al.: Metastatic ovarian tumours: A review of 64 cases. Gynecol Oncol 2003;89: 314–317.
  • 20 Moore RG, Chung M, Granai CO, et al.: Incidence of metastasis to the ovary from nongenital tract primary tumours. Gynecol Oncol 2004;93:87–91.
  • 21 Ayhan A, Guvenal T, Salman MC, et al.: The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries. Gynecol Oncol 2005;98:235– 241.
  • 22 Skirnisdottir I, Garmo H, Holmberg L: Non-genital tract metastases to the ovaries presented as ovarian tumours in Sweden 1990–2003: Occurrence, origin and survival compared to ovarian cancer. Gynecol Oncol 2007;105:166–171.
  • 23 Kiyokawa T, Young RH, Scully RE: Krukenberg tumours of the ovary: A clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations. Am J Surg Pathol 2006;30.
  • 24 Young RH, Scully RE. Metastatic tumours of the ovary. In: Kurman RJ, editor. Blaustein´s Pathology of the Female Genital Tract. 5th edition . New York: Springer-Verlag; 2002.p.1063-101.
  • 25 Mandai M. Krukenberg tumour. CME J Gynaec Oncol. 2004; 4: 112-14.
  • 26 Wright TC,Felix JC. Symptoms are bilateral masse. Contemporary OB/Gynar archive,1996. http:// www.drugtopics.com/be_core/content/journals/g/ data/1996/0900/g9a061.html
  • 27 Prat J, Morice P. Secondary tumours of the ovary. In: Tavassoli FA, Devilee P, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs.Lyon:IARC Press; 2003. p.193-6.
  • 28 Ronnett BM, Kurman RJ, Shmookler BM, et al. The morphologic spectrum of ovarian metastases of appendiceal adenocarcino-mas: a clinico-pathologic and immunohistochemical analysis of tumours often misinterpreted as primary ovarian tumours or metastatic tumours from other gastrointestinal sites. Am J Surg Pathol 1997;21: 1144-55.
  • 29 Householder, JeanMarie, Han, Aaron, Edelson, Mitchell I, Eager, J Michael, Rosenblum, Norman G. Immunohistochemical confirmation of pulmonary papillary adenocarcinoma metastatic to ovaries. Arch Pathol Lab Med. 2002;126:1101-1103.
  • 30 Lee E S, Cho H D, Kim I. The usefulness of CK7 and colon ovarian tumour antigen in differential diagnoses of primary and metastatic ovarian neoplasms. Korean J Pathol. 1998; 32: 201-7.
  • 31 A. Guirguis, E. Elishaev, K. Timms, J. Reid, V. Abkevich, A. Gutin, J. Launchbury, K. Zorn, D. Deloia. Characterization of concurrent ovarian and endometrial carcinoma by copy-number analysis (CNA) and gene expression profiling (GEP). Clin Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 10546.
  • 32 Irving JA, Catasus L, Gallardo A, Bussaglia E, Romero M, Prat J. Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumours and favorable prognosis. Hum Pathol 2005;36(6):605- 19.
  • 33 Mittal K, Soslow R, McCluggage W G. Application of Immunohistochemistry to Gynecologic Pathology. Archives Pathol Lab Medicine. 2008; 5: 13.
  • 34 Peiguo Chu, M.D., Ph.D., Emerald Wu, B.S., Lawrence M Weiss, M.D. Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases. Mod Pathol 2000;13(9):962– 972.
  • 35 McCluggage WG, Young RH. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumours. Semin Diagn Pathol. 2005;22 (1):3-32.